← back to search

Jyoti Nangalia

Wellcome Sanger Institute · GB
Area of research
Hematology · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, and Chronic Myeloid Leukemia Treatments.
h-index
54
citations
23,035
works
178
NIH funding
primary concept
Medicine
email

Recent publications

Clonal dynamics and somatic evolution of haematopoiesis in mouse
Nature 2025cited by 29position: lastdoi
Prolonged persistence of mutagenic DNA lesions in somatic cells
Nature 2025cited by 28position: middledoi
Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis
Nature Genetics 2025cited by 12position: middledoi
JAK2 signalling to HNRNPA1 represses retrotransposon activity in haematopoietic stem cells
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Author Correction: Clonal dynamics and somatic evolution of haematopoiesis in mouse
Nature 2025cited by 0position: lastdoi
Inherited blood cancer predisposition through altered transcription elongation
Cell 2024cited by 25position: middledoi
Clonal dynamics and somatic evolution of haematopoiesis in mouse
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 6position: lastdoi
Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation
Blood 2024cited by 1position: middledoi
Convergent somatic evolution commences in utero in a germline ribosomopathy
Nature Communications 2023cited by 21position: middledoi
Prolonged persistence of mutagenic DNA lesions in stem cells
Research Square 2023cited by 5position: middledoi
The longitudinal dynamics and natural history of clonal haematopoiesis
Nature 2022cited by 353position: middledoi
Bayesian networks elucidate complex genomic landscapes in cancer
Communications Biology 2022cited by 15position: middledoi
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
New England Journal of Medicine 2018cited by 601position: middledoi
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells
Genome Research 2015cited by 172position: middledoi
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
eLife 2014cited by 498position: middledoi
Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions
Journal of Clinical Investigation 2013cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peter J. Campbell · Quotient Clinical (United Kingdom)6 papers (2013–2024) · 5 papers (2022–2024)Emily Mitchell · Wellcome/MRC Cambridge Stem Cell Institute4 papers (2022–2024)E. Joanna Baxter · Bridge University3 papers (2013–2023)Anthony R. Green · Wellcome/MRC Cambridge Stem Cell Institute3 papers (2013–2025)Michael Spencer Chapman · Wellcome Sanger Institute2 papers (2022–2023)Iñigo Martincorena · Wellcome Sanger Institute2 papers (2022–2023)George S. Vassiliou · Wellcome/MRC Cambridge Stem Cell Institute2 papers (2022–2023)Margarete A. Fabre · AstraZeneca (United Kingdom)2 papers (2022–2023)Elisa Laurenti · Wellcome/MRC Cambridge Stem Cell Institute2 papers (2023–2023)Sally Killick · University Hospital Heidelberg1 papers (2023–2023) · 1 papers (2024–2024)Francesco Maura · Palmetto General Hospital1 papers (2022–2022)Edoardo Fiorillo · Institute of Genetic and Biomedical Research1 papers (2022–2022)Eva Hellström‐Lindberg · Karolinska University Hospital1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2023–2023) · 1 papers (2024–2024)Kevin J. Dawson · Wellcome Sanger Institute1 papers (2024–2024) · 1 papers (2023–2023)